Table 3.
Hypothetically achieved doses (Dha) for approaches 1–4 and activities derived from the EANM equations SOP 8 and 9 of Marinelli and Bockisch, respectively
| TUG | NTG | TMG | GD | |
|---|---|---|---|---|
| Dha,1 | 748 (708) | 291 (285) | 234 (177) | 403 (215) |
| Dha,2 | 518 (251) | 182 (70) | 179 (64) | 338 (129) |
| Dha,3 | 489 (196) | 165 (49) | 167 (72) | 313 (114) |
| Dha,4 | 499 (244) | 182 (76) | 179 (68) | 310 (110) |
| Dha,Marinelli | 370 (120) | 149 (39) | 161 (71) | 251 (58) |
| Dha,Bockisch | 379 (127) | 159 (43) | 170 (75) | 251 (60) |
Standard deviations are given in brackets. Standard deviations are highest for calculations performed by approach 1 with fixed activities reflecting the lack of consideration of patient-individual factors
GD Graves’ disease, NTG non-toxic nodular goiter, TMG toxic multinodular goiter, TUG toxic uninodular goiter